ATE544470T1 - Immuntherapeutische methoden und zusammensetzungen - Google Patents

Immuntherapeutische methoden und zusammensetzungen

Info

Publication number
ATE544470T1
ATE544470T1 AT01929778T AT01929778T ATE544470T1 AT E544470 T1 ATE544470 T1 AT E544470T1 AT 01929778 T AT01929778 T AT 01929778T AT 01929778 T AT01929778 T AT 01929778T AT E544470 T1 ATE544470 T1 AT E544470T1
Authority
AT
Austria
Prior art keywords
antigen presenting
presenting cells
compositions
relates
immunotherapeutic methods
Prior art date
Application number
AT01929778T
Other languages
English (en)
Inventor
James Dobbie
Original Assignee
Lamellar Biomedical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lamellar Biomedical Ltd filed Critical Lamellar Biomedical Ltd
Application granted granted Critical
Publication of ATE544470T1 publication Critical patent/ATE544470T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01929778T 2000-03-24 2001-03-26 Immuntherapeutische methoden und zusammensetzungen ATE544470T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0007150.6A GB0007150D0 (en) 2000-03-24 2000-03-24 Immunotherapeutic methods and compositions
PCT/GB2001/001936 WO2001072277A2 (en) 2000-03-24 2001-03-26 Immunotherapeutic methods and compositions

Publications (1)

Publication Number Publication Date
ATE544470T1 true ATE544470T1 (de) 2012-02-15

Family

ID=9888324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01929778T ATE544470T1 (de) 2000-03-24 2001-03-26 Immuntherapeutische methoden und zusammensetzungen

Country Status (13)

Country Link
US (2) US20040110695A1 (de)
EP (1) EP1267924B1 (de)
JP (1) JP2004517031A (de)
AT (1) ATE544470T1 (de)
AU (2) AU2001256461B2 (de)
CA (1) CA2404325C (de)
DK (1) DK1267924T3 (de)
ES (1) ES2382070T3 (de)
GB (1) GB0007150D0 (de)
NO (1) NO333157B1 (de)
NZ (1) NZ522058A (de)
PT (1) PT1267924E (de)
WO (1) WO2001072277A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
KR101192652B1 (ko) * 2003-02-06 2012-10-19 앤저 테라퓨틱스 인코퍼레이티드 비포식 세포로의 침투가 약화된 리스테리아, 리스테리아를 포함하는 백신, 및 그것의 사용방법
US11324698B2 (en) * 2003-08-28 2022-05-10 Vgsk Technologies, Inc. Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
WO2005030226A1 (en) * 2003-09-25 2005-04-07 Lamellar Therapeutics Limited Compositions and methods of using lamellar bodies for therapeutic purposes
JP4987704B2 (ja) * 2004-07-07 2012-07-25 スタテンス セールム インスティトゥート 糖脂質を用いた、脂質系アジュバント製剤を安定化する組成物及び方法
US7465312B2 (en) 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
WO2007130465A2 (en) 2006-05-02 2007-11-15 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
CN102596177B (zh) * 2009-07-01 2014-05-28 阿昂梅迪克斯公司 来源于有核哺乳动物细胞的微囊泡及其应用
BR112013000024B1 (pt) 2010-07-01 2021-11-23 Aeon Medix Inc Composição para entregar um agente anticancer e método para preparação de microvesículas carregadas com um agente anticâncer, a partir de protoplastos de células bacterianas
EP2714017B1 (de) * 2011-06-02 2018-08-01 The Regents of The University of California In membranen verkapselte nanopartikel und verwendungsverfahren dafür
WO2015021390A2 (en) 2013-08-08 2015-02-12 The Regents Of The University Of California Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis
US20170000875A1 (en) 2013-12-02 2017-01-05 Arytha Biosciences, Llc Toxoid preparation and uses thereof
CN106163504B (zh) 2014-03-20 2021-02-09 加利福尼亚大学董事会 水凝胶毒素-吸收或结合纳米颗粒
WO2015187502A1 (en) 2014-06-02 2015-12-10 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders
US10434070B2 (en) 2015-01-02 2019-10-08 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to enable blood transfusion
WO2016176041A1 (en) 2015-04-29 2016-11-03 The Regents Of The University Of California Detoxification using nanoparticles
HK1258650A1 (zh) 2015-09-14 2019-11-15 Vgsk Technologies, Inc. 皮下、舌下和口服治疗用空间稳定载体、用於治疗哺乳动物的组合物和方法
EP3632410A1 (de) 2018-10-05 2020-04-08 Lamellar Biomedical Limited Lipidische polynukleotidträger für die zellabgabe
EP3692984A1 (de) 2019-02-08 2020-08-12 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Annexinbeschichtete partikel
WO2022235907A1 (en) 2021-05-05 2022-11-10 Vgsk Technologies, Inc. Liposome-encapsulated corticosteriods inhibit sars-cov-2 replication and reduces lung inflammation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5403592A (en) * 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
FR2645878B1 (fr) * 1989-04-17 1994-02-25 Institut Nal Sante Recherc Medic Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
EP0544862B1 (de) * 1991-05-29 1998-03-18 Baxter International Inc. 4Verfahren und Zusammensetzungen zur Vorbeugung, Diagnose und Behandlung seröser Entzündungen und damit verbundener Störungen
JPH05339169A (ja) * 1992-03-03 1993-12-21 Dai Ichi Seiyaku Co Ltd 経口ワクチン
US5543152A (en) * 1994-06-20 1996-08-06 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US5462752A (en) * 1994-07-28 1995-10-31 Prp, Inc. Inhibition of platelet binding
US5643599A (en) * 1995-06-07 1997-07-01 President And Fellows Of Harvard College Intracellular delivery of macromolecules
AU6504596A (en) * 1995-07-21 1997-02-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
CA2289742C (en) * 1997-05-08 2013-07-16 Biomira Inc. Method for generating activated t-cells and antigen-pulsed antigen-presenting cells
GB9807298D0 (en) * 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament
EP0976403A1 (de) * 1998-07-30 2000-02-02 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Adjuvans das ein Lungensurfactant enthält
US6193997B1 (en) * 1998-09-27 2001-02-27 Generex Pharmaceuticals Inc. Proteinic drug delivery system using membrane mimetics
US6290987B1 (en) * 1998-09-27 2001-09-18 Generex Pharmaceuticals, Inc. Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
GB0322448D0 (en) * 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules

Also Published As

Publication number Publication date
WO2001072277A2 (en) 2001-10-04
JP2004517031A (ja) 2004-06-10
DK1267924T3 (da) 2012-05-29
NO20024571L (no) 2002-10-14
GB0007150D0 (en) 2000-05-17
CA2404325C (en) 2012-06-12
NZ522058A (en) 2005-05-27
WO2001072277A3 (en) 2002-06-13
NO20024571D0 (no) 2002-09-24
AU2001256461B2 (en) 2005-06-30
EP1267924A2 (de) 2003-01-02
US20040110695A1 (en) 2004-06-10
ES2382070T3 (es) 2012-06-05
PT1267924E (pt) 2012-05-24
NO333157B1 (no) 2013-03-18
CA2404325A1 (en) 2001-10-04
EP1267924B1 (de) 2012-02-08
AU5646101A (en) 2001-10-08
US20080069866A1 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
ATE544470T1 (de) Immuntherapeutische methoden und zusammensetzungen
PT2351579T (pt) Vacinas polipeptídicas para proteção ampla contra linhagens meningocócicas hipervirulentas
NZ331651A (en) BSW17 peptide immunogens for vaccination against and treatment of allergy
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
AU6632496A (en) Cell derived antigen presenting vesicles
DE69314020D1 (de) Impfstoffe die nicht ionische tensid vesikeln enthalften
WO2005037190A3 (en) Multiplex vaccines
GB0130123D0 (en) Outer membrane vesicle vaccine and its preparation
IL150602A0 (en) Proteosome influenza vaccine
OA09800A (en) Vaccine compositions containing liposomes.
TW200510538A (en) Functionally reconstituted viral membranes containing adjuvant
GR3017778T3 (en) Immunogenic complexes, in particular iscoms.
ES2177927T3 (es) Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico.
DE60137347D1 (de) Neuer immunogener komplex
WO2004030616A3 (en) Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
AU6078399A (en) Ligand presenting assembly (lpa), method of preparation and uses thereof
WO2004033483A3 (en) Liposomal system and method of using same
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
WO1999047102A3 (en) Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
Guan Development of liposomal antigen delivery system for synthetic muc1 peptides